• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Product Classification

  • Print
  • Share
  • E-mail
New Search Back to Search Results
Device continuous glucose monitor, implanted, adjunctive use
Definition The device is a fully implanted continuous glucose monitoring device intended to detect trends and track patterns in interstitial glucose values. The device is indicated for use as an adjunctive device to complement, not replace, information obtained from standard home blood glucose monitoring devices.
Physical State This device comprises a subcutaneously implanted sensor containing the glucose specific biological sensor, an algorithm that converts sensor signals into glucose values, a display device that provides glucose values to the user, and a mechanism for transmitting data from the sensor to the display device.
Technical Method Signals from an implanted (subcutaneous) glucose specific biological sensor are algorithmically converted to glucose values which are provided to the user.
Target Area Interstitial fluid
Review Panel Clinical Chemistry
Product CodeQCD
Premarket Review Division of Chemistry and Toxicology Devices (DCTD)
Division of Chemistry and Toxicology Devices (DCTD)
Submission Type PMA
Device Class 3
Total Product Life Cycle (TPLC) TPLC Product Code Report
GMP Exempt? No
Summary Malfunction
Implanted Device? Yes
Life-Sustain/Support Device? No
Recognized Consensus Standard
Third Party Review Not Third Party Eligible